Andrew Hirsch
Chief Executive Officer chez C4 THERAPEUTICS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Andrew J.
Hirsch is currently the President, Chief Executive Officer & Director at C4 Therapeutics, Inc. since 2020.
He is also an Independent Director at Editas Medicine, Inc. since 2017.
Previously, he held positions such as President, CEO, CAO & Director at DNIB Unwind, Inc. from 2012 to 2016, VP-Corporate Strategy, Mergers & Acquisitions at Biogen, Inc. from 2002 to 2011, CFO & Head-Corporate Development at Agios Pharmaceuticals, Inc. from 2016 to 2020, and Chief Financial Officer at Avila Therapeutics, Inc. from 2011 to 2012.
Mr. Hirsch completed his undergraduate degree at the University of Pennsylvania in 1992 and obtained an MBA from the Tuck School of Business at Dartmouth in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
0,31% | 15/02/2024 | 210 741 ( 0,31% ) | 2 M $ | 31/03/2024 |
EDITAS MEDICINE, INC.
0,00% | 01/06/2023 | 2 000 ( 0,00% ) | 14 840 $ | 31/03/2024 |
Postes actifs de Andrew Hirsch
| Sociétés | Poste | Début |
|---|---|---|
| EDITAS MEDICINE, INC. | Director/Board Member | 30/05/2017 |
| C4 THERAPEUTICS, INC. | Chief Executive Officer | 02/10/2020 |
Anciens postes connus de Andrew Hirsch
| Sociétés | Poste | Fin |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director of Finance/CFO | 11/09/2020 |
| DNIB UNWIND INC | Chief Executive Officer | 24/07/2016 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Director of Finance/CFO | 31/03/2012 |
| BIOGEN INC. | Corporate Officer/Principal | 01/06/2011 |
Formation de Andrew Hirsch
| University of Pennsylvania | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Health Technology |
